News

LendingTree Reports Significant Revenue Growth in Q3 Results

LendingTree Reports Significant Revenue Growth in Q3 Results

LendingTree's Third Quarter Performance Highlights

LendingTree, Inc. (NASDAQ: TREE) has officially released its financial results for the third quarter of 2024, showcasing an impressive increase in revenue. The company reported consolidated revenue of $260.8 million, reflecting a remarkable growth of 68% compared to the previous year. This growth is largely attributed to exceptional performance within its insurance segment, which surged by an astounding 210% year-over-year.

Financial Overview

Despite the positive revenue growth, the company incurred a GAAP net loss of $(58.0) million, translating to $(4.34) per diluted share. This loss included a significant non-cash impairment of equity investments amounting to $(58.4) million, indicating that while revenue metrics look favorable, challenges remain in profitability. LendingTree's variable marketing margin reached $77.2 million, contributing positively to the overall financial picture. Additionally, adjusted EBITDA was reported at $26.9 million, indicating a robust operational performance.

Segment Contributions and Trends

The performance of LendingTree's various segments paints a detailed picture of the company’s strengths and weaknesses:

  • Home Segment: This segment recorded revenues of $32.2 million, a 4% decline from the same quarter last year, with a segment profit of $9.3 million.
  • Consumer Segment: Revenue in this category was $59.5 million, down 12% compared to the previous year, although it did show a sequential growth of 6%.
  • Insurance Segment: The star of the show, this segment accounted for $169.1 million in revenue and a record profit of $41.4 million, a breathtaking 77% increase compared to the prior period.

Strategic Insights from Leadership

Doug Lebda, Chairman and CEO, remarked on the quarter's results, highlighting the considerable growth in the insurance segment as a pivotal aspect of the company’s success. He stated, "Our Insurance segment had another quarter of tremendous growth, as revenue increased 210% compared to the prior year period. Improving results in personal loans and a 32% YoY increase in small business revenue drove 6% sequential growth in the Consumer segment revenue."

Furthermore, Scott Peyree, President and COO, noted the stability within their insurance business, indicating that it is well positioned for ongoing expansion as market conditions improve. Jason Bengel, CFO, highlighted future growth prospects alongside disciplined expense management, foreshadowing potential capital structure optimization to enhance profitability.

Financial Outlook and Projections

Looking ahead, LendingTree has revised its revenue outlook for the full-year 2024, expecting it to range between $870 million and $880 million, improving from the prior estimate of $830 million to $870 million. For the fourth quarter, the forecast suggests a revenue expectation of $231 million to $241 million, along with an adjusted EBITDA forecast of $20 million to $23 million.

However, it's important to note that LendingTree is unable to provide a reconciliation of projected adjusted EBITDA to the GAAP results due to the influence of legal and tax matters that could change actual results significantly.

Conclusion

LendingTree's robust financial results display its resilience and strategic positioning in an evolving market. With continued growth in its insurance sector and a focus on streamlining operations across its segments, the company appears poised to enhance both its revenue performance and investor confidence going forward.

Frequently Asked Questions

What were LendingTree's total revenues for the third quarter?

For the third quarter of 2024, LendingTree reported consolidated revenues of $260.8 million.

How much did LendingTree lose in net profit for Q3 2024?

LendingTree recorded a GAAP net loss of $(58.0) million or $(4.34) per diluted share.

Which segment of LendingTree showed the highest growth?

The Insurance segment showcased the most impressive growth, increasing revenue by 210% year-over-year.

What is the adjusted EBITDA reported by LendingTree?

LendingTree reported an adjusted EBITDA of $26.9 million for the third quarter of 2024.

What is the projected revenue range for LendingTree for full-year 2024?

LendingTree has updated its revenue outlook for full-year 2024 to be between $870 million and $880 million.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

NYSE Reflects on 9/11: Honoring Lives and Legacy

Updated Category News Views 6

A Somber Day at NYSE: Reflecting on 9/11 September 11th grips the heart of NYSE every year, but this year's 25th-anniversary powerfully reverberates through its hallowed halls. The hustle of the trading floor halts for a moment at 9:20 AM ET, paying homage to those lost in the harrowing attacks. I've seen the markets flap in the wind of countless crises, but nothing's...

Continue Reading
High-Grade Copper Spurs Optimism for PolarX in Alaska

Updated Category News Views 4

Copper's New Pulse: PolarX Makes Waves in Alaska Ever hear about striking copper so rich it's practically shimmering? Well, PolarX Limited just might have hit that sweet spot up in the rugged expanses of Alaska. Let me tell you, when you're knee-deep in resources, like what they’re discovering at the Caribou Dome Project, it sure feels like you’ve struck modern-day...

Continue Reading
Modeling and Mental Health Join Forces for Wellness

Updated Category News Views 4

A Fresh Alliance for Mental Wellness in Modeling Alright, let's shine a spotlight on a significant step in the modeling industry, a place typically less vocal about mental health. In a move that feels long overdue, Brain-Body Therapy and Mother Model Management have joined forces, marking the beginning of a collaborative effort to propel mental wellness to the forefront...

Continue Reading
Oil Markets Shift Focus: Pipelines Trump Drilling

Updated Category News Views 7

Decoupling Oil Price and Production Response This oil market isn’t your usual rodeo. With Brent flirting with $100, it’s a seismic shift that’s not yielding new drills but redirecting capital to the existing infrastructure landscape. Ask yourself why we're not seeing the usual cavalry charge of new rigs. It’s simple: Pipeline mileage and producing wells have...

Continue Reading
DCM Services Teams with AKUVO to Boost Estate Recoveries

Updated Category News Views 14

Revolutionizing Estate Recovery Practices Here's the scoop: DCM Services (DCMS), that big shot in estate account resolution, is hooking up with AKUVO to shake up how credit unions handle estate recoveries. This alliance is a clear nod to modernizing a process stuck in the past. Let’s face it, handling decedent and probate accounts is no cakewalk, and traditional methods...

Continue Reading
Fermi's Founder Pushes for Board Overhaul: What's Next?

Updated Category News Views 4

Fermi's Roller Coaster: A Founder’s Stand Seems like Fermi Inc. is on a wild ride through the business landscape, and it's giving shareholders more whiplash than satisfaction these days. Toby Neugebauer, co-founder of Fermi and the loudest voice in the room, is feeling like his company is facing some serious turbulence and seems determined not to sit idly by as it hits...

Continue Reading
Intus Bio Secures $2.7M for Colorectal Cancer Test

Updated Category News Views 5

Pioneering Efforts in Early-Onset Colorectal Cancer Detection The battlefield of colorectal cancer prevention just got a serious upgrade with Intus Bio grabbing a $2.7 million award. This ain't just pocket change—it's a shot at rewriting the script on how we approach early-onset colorectal cancer, the pesky number one cancer gnawing at the under-50 crowd. Partnering...

Continue Reading
QuickFi Nabs Top Finovate Award for Fourth Time

Updated Category News Views 5

An Unstoppable Force in Fintech Well, if QuickFi hasn't made a name for itself in fintech, then folks, I don't know what to tell you. This year, they’ve snagged yet another prestigious Finovate Award—this time for Best SMB/SME Banking Solution. That's not their first rodeo either; it’s the fourth time they’ve walked away winners. It's almost like they're...

Continue Reading
Supply Maverick Simplifies Global Shipping Processes

Updated Category News Views 5

Paving the Way for Seamless International Shipping Supply Maverick's got a new mantra, folks: simplicity. They're slicing through the mess of international shipping and bringing some much-needed clarity for customers in Canada, Australia, and New Zealand. It’s about time someone shook up the logistics playbook. The Nuts and Bolts of the New Shipping System Imagine being...

Continue Reading
Melissa Rivers Brings Her Wit Back to Emmys Carpet

Updated Category News Views 11

They say you can never go home again, but don't tell that to Melissa Rivers. Rolling the dice on nostalgia and kicking off a new chapter, she's waltzing back to the Emmys red carpet for the first time in nearly 20 years. Alright, what's in it for investors? Not much—unless you're looking to invest in nostalgia. But there's something here about legacy, reinvention, and...

Continue Reading

Top 5 Most Recently Viewed Articles

LendingTree Reports Significant Revenue Growth in Q3 Results

Updated Category News Views 79

LendingTree's Third Quarter Performance Highlights LendingTree, Inc. (NASDAQ: TREE) has officially released its financial results for the third quarter of 2024, showcasing an impressive increase in revenue. The company reported consolidated revenue of $260.8 million, reflecting a remarkable growth of 68% compared to the previous year. This growth is largely attributed to...

Continue Reading
Phoenix Asia Holdings Limited Launches Successful IPO Journey

Updated Category News Views 418

Phoenix Asia Holdings Limited Launches Successful IPO Journey Phoenix Asia Holdings Limited, a remarkable player in Hong Kong's construction industry, has just announced its initial public offering. This offering allows them to share a piece of their promising future with investors, setting the stage for enhanced growth and development within their sector. IPO Pricing...

Continue Reading
Afarak Group Enhances Chrome Ore Production with Green Initiatives

Updated Category News Views 221

Afarak Group's Investment in Chrome Ore Production Afarak Group SE is making significant strides in enhancing its production of metallurgical grade chrome ore concentrate. This initiative is taking place at their Vlakpoort Mine, where a new processing plant is being commissioned to support increased production capabilities. Innovative Production Techniques The new chrome...

Continue Reading
Understanding Recent Bearish Activity in BridgeBio Pharma Options

Updated Category News Views 145

BridgeBio Pharma's Options Trends Investors have sharply turned bearish on BridgeBio Pharma (NASDAQ: BBIO), marking a noteworthy shift that warrants attention from retail traders. This unusual behavior, highlighted by significant options trading volumes, points towards possible insider intentions or unforeseen market changes. Recent Market Movements in BBIO Options The...

Continue Reading
Nasus Pharma Expands Development Agreement for NS002 Product

Updated Category News Views 226

Nasus Pharma Strengthens Development Plans for NS002 Nasus Pharma Ltd. (NYSE: NSRX), a prominent player in the field of clinical-stage pharmaceuticals, has taken a monumental step forward in its mission to provide innovative emergency treatments. In its latest announcement, Nasus Pharma has established a pivotal agreement with Aptar France S.A.S. and AptarGroup, Inc.,...

Continue Reading